Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances.
about
Mechanistic Perspectives of Maslinic Acid in Targeting InflammationTargeting inflammation: multiple innovative ways to reduce prostaglandin E₂The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunityLipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitusNovel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathwayPhysiopathology of the cochlear microcirculationCOX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis.A knowledge-based T2-statistic to perform pathway analysis for quantitative proteomic data.Identification of a novel class of anti-inflammatory compounds with anti-tumor activity in colorectal and lung cancers.Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth.Prostaglandins and inflammation.Dipetalodipin, a novel multifunctional salivary lipocalin that inhibits platelet aggregation, vasoconstriction, and angiogenesis through unique binding specificity for TXA2, PGF2alpha, and 15(S)-HETE.Synergistic suppression of early phase of adipogenesis by microsomal PGE synthase-1 (PTGES1)-produced PGE2 and aldo-keto reductase 1B3-produced PGF2α.Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity.Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.EP₃ receptors mediate PGE₂-induced hypothalamic paraventricular nucleus excitation and sympathetic activation.PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway.Inhibitory effect of triterpenoids from Dillenia serrata (Dilleniaceae) on prostaglandin E2 production and quantitative HPLC analysis of its koetjapic acid and betulinic acid contents.Prostaglandins in cancer cell adhesion, migration, and invasionAssociations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.Inhibition of STAT3- and MAPK-dependent PGE2 synthesis ameliorates phagocytosis of fibrillar β-amyloid peptide (1-42) via EP2 receptor in EMF-stimulated N9 microglial cells.MicroRNA and AU-rich element regulation of prostaglandin synthesisMicroenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathway.Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.Plasma oxylipin profiling identifies polyunsaturated vicinal diols as responsive to arachidonic acid and docosahexaenoic acid intake in growing piglets.The prostaglandin E2 receptor EP4 is integral to a positive feedback loop for prostaglandin E2 production in human macrophages infected with Mycobacterium tuberculosis.The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cellsReduced T cell-dependent humoral immune response in microsomal prostaglandin E synthase-1 null mice is mediated by nonhematopoietic cells.Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer.Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor traffickingThe neurobiology of lipid metabolism in autism spectrum disorders.Regulation and dysregulation of innate immunity by NFAT signaling downstream of pattern recognition receptors (PRRs).The multiple faces of prostaglandin E2 G-protein coupled receptor signaling during the dendritic cell life cycle.Role of CD14 in host protection against infections and in metabolism regulation.Prostaglandin EP4 antagonists.Signaling pathways involved in MDSC regulation.Prenatal exposure to common environmental factors affects brain lipids and increases risk of developing autism spectrum disorders.Docosahexaenoic acid differentially affects TNFα and IL-6 expression in LPS-stimulated RAW 264.7 murine macrophages.Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells.Bioactive Extract from Moringa oleifera Inhibits the Pro-inflammatory Mediators in Lipopolysaccharide Stimulated Macrophages.
P2860
Q26780534-70FA9D1A-AFE7-47DA-A6A7-800906C6B8F9Q27008521-92727A07-5744-4928-B2CA-8917F31B3525Q27021651-08F18BFB-A015-4531-A7B9-45A4AF047DC7Q28080521-0357C1CE-BD06-4124-B742-274E3286177BQ28083349-140AFA9B-53CC-42A6-A62F-E58EE7CA52A4Q30456047-08A7FA57-8CF3-4F3B-B6A1-93696312A5B2Q33682193-3301FF4A-3800-47FC-8C5F-74EC689C86D3Q33860424-B067E124-E57D-4177-B18D-499AD3BDC30FQ34024178-3227A866-A93C-498D-BB39-AACEF6FC980BQ34069510-E6948AA3-149E-4E43-955E-75B3E559F8EDQ34179727-6153142A-1FF5-4054-AF94-08ACF16EEE7AQ34385719-6CE5745B-7867-4DBF-84AC-973EFFD78866Q34412709-F7E9E681-964B-41C5-AB68-8B349A0BB4E3Q34954633-AE35E084-562A-4444-9598-8E801FFD70C1Q35376020-8F6A0E2F-A958-4023-9827-03EA93A2ED47Q35395904-E0A3EAFA-D479-4765-BB5E-42E2EA951149Q35553645-CA0912C9-A941-49C2-8228-DD387F0E31A7Q35562990-5A65A22B-84C7-4B79-9506-AFCF842A014DQ35821653-F4412E67-37AB-45B3-958B-AEFDE9CD652DQ35860732-6EDEE740-4F59-4531-9E42-3802445227B2Q36200280-B3092F08-86CB-444B-B026-7088BA0CD40CQ36249379-3D6C9BD1-8E25-4C71-A152-86FE30624FD6Q36718698-305B5A7D-E9BA-4B92-8FD2-8636B4309C39Q36806255-2780393B-7E65-46DB-8B66-618B726FE03AQ36822568-F7609FAD-16BA-4DEB-91BC-C76A9A7DCFA6Q37118747-0F3B0CD7-A0A0-4B18-ADB7-13A61296CC94Q37288834-9F7FBF3E-72F3-4BFC-B74C-AEFBC97D493FQ37334207-58A8C877-1D69-4E85-98B6-C688C26E2992Q37366238-01C9CAC9-26FE-46BC-9D34-EB914423CF23Q37794776-1D5429A5-EC15-4DB7-8B0F-3CD5B2DF8675Q37846445-37C5F0B5-FAC4-417A-BA4C-8C2CADC8D5E9Q38019405-B72309E9-9EF4-41E6-9958-643F55DAB0DFQ38093015-9461A03E-EA2A-44E2-8B05-D630B9CEB7FCQ38125198-02E42A39-C58F-44B9-B5BA-F08C197895F6Q38162977-09E8C230-6580-4929-87D9-C26C90ACA3DEQ38204175-983BAB30-8BB5-47C1-9D8C-F3AA7EB9BE3FQ38555255-00249A1C-5893-4C3F-916F-06AFC1EAD280Q38881211-F0AEE07A-1304-4B2F-A070-13C1049912A1Q38892383-E84898BC-0F9F-4E86-8B92-BC29D9F1A838Q38922666-B7DC6AFF-5C52-48C3-8042-2D8B0DE268C9
P2860
Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prostaglandin E2 at new glance ...... ity offer therapeutic chances.
@ast
Prostaglandin E2 at new glance ...... ity offer therapeutic chances.
@en
type
label
Prostaglandin E2 at new glance ...... ity offer therapeutic chances.
@ast
Prostaglandin E2 at new glance ...... ity offer therapeutic chances.
@en
prefLabel
Prostaglandin E2 at new glance ...... ity offer therapeutic chances.
@ast
Prostaglandin E2 at new glance ...... ity offer therapeutic chances.
@en
P1476
Prostaglandin E2 at new glance ...... sity offer therapeutic chances
@en
P2093
Markus Bruckner
Petra Krause
P304
P356
10.1016/J.BIOCEL.2009.09.015
P577
2009-09-27T00:00:00Z